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Abstract
Purpose This study investigated the effect of small manipulations in carbohydrate (CHO) dose on exogenous and endogenous 
(liver and muscle) fuel selection during exercise.
Method Eleven trained males cycled in a double-blind randomised order on 4 occasions at 60% V̇O
2max for 3 h, followed 
by a 30-min time-trial whilst ingesting either 80 g h−1 or 90 g h−1 or 100 g h−1 13C-glucose-13C-fructose [2:1] or placebo. 
CHO doses met, were marginally lower, or above previously reported intestinal saturation for glucose–fructose (90 g h−1). 
Indirect calorimetry and stable mass isotope  [13C] techniques were utilised to determine fuel use.
Result Time-trial performance was 86.5 to 93%, ‘likely, probable’ improved with 90 g h−1 compared 80 and 100 g h−1. Exog-
enous CHO oxidation in the final hour was 9.8–10.0% higher with 100 g h−1 compared with 80 and 90 g h−1 (ES = 0.64–0.70, 
95% CI 9.6, 1.4 to 17.7 and 8.2, 2.1 to 18.6). However, increasing CHO dose (100 g h−1) increased muscle glycogen use 
(101.6 ± 16.6 g, ES = 0.60, 16.1, 0.9 to 31.4) and its relative contribution to energy expenditure (5.6 ± 8.4%, ES = 0.72, 5.6, 
1.5 to 9.8 g) compared with 90 g h−1. Absolute and relative muscle glycogen oxidation between 80 and 90 g h−1 were similar 
(ES = 0.23 and 0.38) though a small absolute (85.4 ± 29.3 g, 6.2, − 23.5 to 11.1) and relative (34.9 ± 9.1 g, − 3.5, − 9.6 to 2.6) 
reduction was seen in 90 g h−1 compared with 100 g h−1. Liver glycogen oxidation was not significantly different between 
conditions (ES < 0.42). Total fat oxidation during the 3-h ride was similar in CHO conditions (ES < 0.28) but suppressed 
compared with placebo (ES = 1.05–1.51).
Conclusion ‘Overdosing’ intestinal transport for glucose–fructose appears to increase muscle glycogen reliance and nega-
tively impact subsequent TT performance.
Keywords Muscle glycogen · Carbohydrate ingestion · Stable isotope · Exercise · Metabolism
Abbreviations
CHO  Carbohydrate
CV  Coefficient of variation
ES  Effect size
GLUT5  Glucose transporter 5
HR  Heart rate
IRMS  Isotope ratio mass spectronomy
NMRS  Nuclear magnetic resonance spectroscopy
PLA  Placebo
SGLT1  Sodium-dependent glucose transporter 1
TT  Time trial
V̇O2max  Maximal oxygen uptake
Introduction
Fuel selection and energy expenditure during prolonged 
exercise are influenced by exercise intensity (Romijn et al. 
1993) and exogenous substrate availability (Cox et al. 2016; 
King et al. 2018). The performance benefit of ingesting 
exogenous carbohydrate (CHO) is well documented (Currell 
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and Jeukendrup 2008; McConell et al. 1999; Smith et al. 
2010, 2013); however, the glycogen sparing capacity of 
exogenous CHO has received equivocal evidence (Newell 
et al. 2018) and may be dependent on the composition and 
dose of the ingested CHO. Furthermore, based on recent 
observations, the optimal CHO dose during exercise lasting 
more than 2–2.5 h may also be sensitive to ‘over-dosing’ the 
intestinal transport proteins for glucose and/or fructose is 
detrimental to substrate utilisation and exercise performance 
(King et al. 2018).
Exogenous CHO oxidation is increased when glu-
cose–fructose formulations (relative to glucose only) are 
ingested at a rate of ~ 90 g h−1 during exercise (Jentjens et al. 
2004a, b, 2006). Previously, maintaining high exogenous 
CHO oxidation rates was suggested as a possible mechanism 
behind the ergogenic effect of CHO ingestion during exer-
cise (Jeukendrup 2008). But many studies investigating more 
than one CHO dose or formulation (e.g. glucose–fructose, 
glucose–sucrose mixtures) either did not measure exercise 
performance with possible beneficial exogenous CHO oxida-
tion (Jentjens et al. 2004a, b, 2005) or exogenous oxidation 
with promising performance data (Baur et al. 2014; Smith 
et al. 2013; Tripplett et al. 2010).
The CHO dose may also play an important role and it 
remains to be seen if the CHO dose can be further optimised 
around the proposed upper limit for intestinal absorption 
of 90 g h−1 during endurance exercise of prolonged dura-
tion. Previously, we reported a dose effect of CHO ingestion 
on substrate utilisation during 2 h of high intensity (77% 
V̇O2max ) cycling and performance in a 30-min time trial 
(King et al. 2018). Ingestion of a glucose–fructose solution 
(2:1) attenuated the rate of muscle glycogen oxidation with 
a small reduction in liver glycogen oxidation when the dose 
was sufficient (90 g h−1) to saturate the intestinal transport 
proteins, sodium-dependent glucose transporter 1 (SGLT1) 
and glucose transporter 5 (GLUT5). However, exceeding 
intestinal saturation rates for glucose–fructose increased the 
reliance on pre-existing stores of muscle glycogen, which 
had a detrimental effect on performance. In this respect, the 
90 g h−1 dose of glucose–fructose was optimal for substrate 
utilisation and performance and agrees with previous per-
formance (Smith et al. 2013) and hepatic glycogen oxida-
tion data (Gonzalez et al. 2015). In contrast, the latter of 
these studies reported no change in muscle glycogen oxida-
tion. This may in part be due to a methodological limita-
tion in quantifying glycogen oxidation post-exercise with 
NMRS, but also attributable to the lower exercise intensity 
(50% Wpeak), where muscle glycogen may not be as crucial 
to prolonged exercise performance. Furthermore, the glu-
cose–fructose dose used by Gonzalez et al. (2015) may have 
slightly exceeded intestinal transport, which may be detri-
mental to fuel utilisation and performance. It also remains 
to be seen if glucose:fructose doses can be optimised around 
the 90 g h−1 proposed upper limit and if any endogenous 
fuel utilisation effects remain at longer duration and lower 
intensity exercise.
As many endurance sports require performance in excess 
of 3 h, optimising fuelling strategies is a key concern for 
athletes and practitioners. However, empirical data on the 
role of multiple transportable CHO dose on endogenous fuel 
use in exercise lasting this long have not been researched. 
Therefore, this study sought to investigate if small alterations 
in ingested CHO dose affect liver and muscle glycogen uti-
lisation during 3 h of prolonged exercise. It is hypothesised 
that exceeding the intestinal saturation rates for glucose and 
fructose will negatively affect substrate utilisation and exer-
cise performance.
Methods
Participants
Eleven trained, healthy male cyclists volunteered to partici-
pate in this study. Participants were required to have trained 
for > 3 times per week in cycling-specific training for at least 
the last 2 years. The mean age, body mass, stature, V̇O2max , 
and maximal power output (Wmax) were 30.3 ± 6.5 years, 
78.2 ± 10.5 kg, 179.6 ± 5.8 cm, 60.0 ± 4.3 ml kg−1 min−1, 
and 329.5 ± 33.2 W, respectively. Procedures and potential 
risks were explained before the study and all participants 
provided written informed consent. The study received insti-
tutional ethics approval conducted in accordance with the 
Declaration of Helsinki.
Preliminary testing
Preliminary testing consisted of two parts: a maximal incre-
mental cycle test to volitional exhaustion to determine Wmax 
and V̇O2max , and a familiarisation effort for the 30-min 
time trial (TT) used to quantify exercise performance in the 
subsequent experimental trials. The objective of the TT was 
to complete the maximum amount of work possible within 
30 min. This visit was conducted 1 week before the first 
experimental trial on an SRM high-performance ergometer 
(SRM, Germany) as described in detail elsewhere (King 
et al. 2018).
Experimental design
Participants completed four experimental trials (each sep-
arated by 7 days) consisting of 180 min cycling at 60% 
V̇O2max , followed by a 30 min self-paced TT. The exercise 
intensity was chosen to represent a moderate intensity but 
glycogen demanding state (Van Loon et al. 2001) and the 
average energy demands of prolonged stage racing (Ebert 
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et al. 2006). During each trial participants ingested 250 ml 
of one of four drinks solutions every fifteen minutes (starting 
at minute 15 into the exercise protocol). Three CHO solu-
tions, each enriched with 150 mg per 75 g CHO of a univer-
sally labelled (U-13C6) glucose and fructose tracer (Sigma 
Aldrich, St Louis, MO) providing 80 g, 90 g and 100 g of 
glucose (D-glucose; Thornton and Ross Ltd, Huddersfield, 
UK) and fructose (Danisco, Kettering, UK) (glucose–fruc-
tose ratio 2:1) were prescribed in a randomised, double-
blind design. A placebo trial (PLA) was also conducted to 
determine the background appearance of 13CO2 in expired 
air and the metabolic response without CHO ingestion. All 
formulations contained 26 mmol L−1 of NaCl (Saxa, Herts, 
UK), as well as artificial sweetener (aspartame, Morrisons’ 
plc, Bradford, UK) to blind the participants to each con-
dition. The isotopic composition of the stock glucose and 
fructose was measured by isotope ratio mass spectrometry 
(IRMS (Isoprime, Cheadle, UK)), using L-fucose as an iso-
topic internal standard as previously described (Morrison 
et al. 2011) and determined to be − 25.68‰ and − 12.27‰ 
respectively. All 13C measurements are quoted with refer-
ence to the internationally accepted standard for carbon iso-
tope measurements, Vienna Pee Dee Belemnite (VPDB). 
The final isotopic enrichment of the ingested CHO solutions 
was: 80 g h−1 = 146.20 ± 9.92‰, 90 g h−1 = 149.18 ± 3.19‰ 
and 100 g h−1 = 145.70 ± 6.97‰. All 13C measurements 
are quoted with reference to the internationally accepted 
standard for carbon isotope measurements, Vienna Pee Dee 
Belemnite (VPDB).
Diet and physical activity before testing
Participants recorded their food intake and physical activ-
ity during the 48 h before the first experimental trial and 
were instructed to repeat the same diet and activity pattern 
in the 48 h before subsequent trials. In the 24 h before each 
experimental trial, participants were required to not under-
take any strenuous physical activity and avoid alcohol and 
caffeine consumption. Further, participants were also asked 
to undergo an intense training session 48 h before each visit 
to deplete glycogen stores, reducing background levels of 
13Carbon (Harvey et al. 2007). Throughout the experimental 
trials, participants were asked to refrain from ingesting foods 
with a high natural 13C:12C abundance (i.e. plants with a C4 
photosynthetic cycle, or animals fed with such plants). Each 
participant was provided with a list of foods to avoid (Mor-
rison et al. 2000). This precaution ensures that background 
13C enrichment of expired  CO2 from endogenous substrate 
stores is less likely to be affected by unintentional but natural 
fluctuations of dietary 13C. Before each test, a standardised 
evening meal was consumed 10–12 h before arrival at the 
laboratory (total, 1443 kcal; 53% CHO, 17% fat, and 30% 
protein) and participants were instructed to consume 500 ml 
of water on the morning of each trial.
Experimental trials
After a 10–12 h overnight fast, participants reported to the 
laboratory on each occasion between 0700 h and 0900 h. 
Upon arrival at the laboratory, an in dwelling catheter (20 
gauge Introcan Safety®, B. Braun Medical Ltd., Sheffield, 
UK) was inserted into an antecubital vein for regular blood 
sampling. Over the next 10 min resting V̇O2 and V̇CO2 
measurements were made with participants sitting on the 
cycle ergometer using an online gas analysis system (Meta-
lyser, Cortex, Germany), which was calibrated following 
the manufacturer’s instructions. For the measurement of 
13CO2:12CO2 in expired air at rest, 12 ml Exetainers (SerCon 
Ltd, Crewe, UK) of expired gas were collected in duplicate 
via a mixing chamber (Jaeger, Germany).
Participants then completed 180 min of cycling at 60% 
V̇O2max on a high-performance ergometer. V̇O2,V̇CO2 and 
heart rate (HR) were measured for 5 min every 15 min until 
the end of exercise. Samples of expired gas for 13CO2:12CO2 
analysis were collected during the final 60 s of each 15-min 
period. Samples for the analysis of plasma glucose, plasma 
lactate, serum insulin, serum-free fatty acids were drawn 
every 15 min and for 13C plasma glucose enrichment at 
60 min and every 30 min thereafter. Following each com-
pleted 15-min period of data collection, one of the 250 ml 
drink solutions was given to the participants, who were 
instructed to consume the drink as quickly as comfortably 
possible.
Analyses
Aliquots of plasma and serum prepared by centrifugation 
were analysed for selected metabolites. Glucose (glucose 
oxidase kit; Instrumentation Laboratory, Monza, Italy, Inter 
assay CV: 4.9%, Intra assay CV: 2.3%) and lactate (Lactate 
kit, Randox, County Antrim, UK, Inter CV: 4.5%, Intra CV: 
2.7%) were analysed by spectrophotometry (iLab 300 plus, 
ILab, UK). Insulin was analysed using a chemoilumino-
metric immunoassay (ADIVA Centaur, Bayer diagnostics, 
Berkshire, UK, Inter CV: 3.2–4.6%, Intra CV: 2.6–5.9%). 
Non-esterified free fatty acid content of serum was analysed 
by an acyl-CoA synthetase and oxidase assay (NEFA-HR2, 
Wako Chemicals GmbH, Germany, Inter assay CV: 1.5%).
The 13CO2:12CO2 in expired air was determined by IRMS. 
The isotopic ratio (13C:12C) is derived against laboratory  CO2 
(itself calibrated against VPDB) from the ion beam area ratio 
measurements with correction of the small contribution of 
12C16O17O at m/z 45 [Craig correction; (Craig 1957)]. The 
13C:12C in plasma glucose was determined using LC-IRMS as 
described in detail previously (Morrison et al. 2011). Plasma 
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samples were prepared by ultrafiltration (30,000 molecular 
weight cutoff tubes, Amicon Ultra 4, Millipore, Watford, UK), 
with an internal standard added (L-fucose,  C6H12O5, Sigma-
Aldrich) and separated by liquid chromatography to separate 
the glucose from other constituents prior to “wet-oxidation” 
and IRMS analysis of the resulting  CO2.
Calculations
Total CHO and fat oxidation (g.min−1) were computed from 
V̇O2 and V̇CO2 (L.min−1) using the stoichiometric equations 
of Frayn (Frayn 1983), with protein oxidation during exercise 
assumed to be negligible.
The isotopic enrichment of the ingested glucose and fruc-
tose, (Rexo), and expired air (Rexp) was expressed in standard 
δ13C units (‰) relative to VPDB (Craig 1953). Exogenous 
glucose oxidation derived from glucose and the combined 
ingestion of glucose and fructose  (CHOEX) was computed 
using the following equation (Peronnet et al. 1990), with the 
placebo condition establishing the background 13CO2:12CO2 
during exercise.
where V̇CO2 is in L.min−1, Rexp is the isotopic composition 
of expired  CO2, Rref is the isotopic composition of expired 
 CO2 at the same time point with ingestion of placebo, Rexo 
is the isotopic composition of the ingested solution and k 
(0.747 L g−1) is the volume of  CO2 provided by the complete 
oxidation of glucose.
Computations were made on the assumption that, in 
response to exercise, 13C is not irreversibly lost in pools of 
tricarboxylic acid cycle intermediates and/or bicarbonate and 
that 13CO2 recovery in expired gases was complete or almost 
complete during exercise (Trimmer et al. 2001). Such compu-
tation has been shown to underestimate exogenous oxidation 
rates at the beginning of exercise because of the delay between 
13CO2 production in tissues and its exhalation (Pallikarakis 
et al. 1991). Therefore, carbohydrate oxidation data are pre-
sented for the second and third hours of the 3-h protocol to 
allow for a steady-state condition of 13C in the bicarbonate 
pool to be reached (Robert et al. 1987).
Based on the 13C isotopic composition of plasma glucose 
(Rglu), the oxidation rate of plasma CHO was calculated (Per-
onnet et al. 1998):
(1)CHO =
(
4.55 × V̇CO2
)
−
(
3.21 × V̇O2
)
(2)Fat =
(
1.67 × V̇O2
)
−
(
1.67 × V̇CO2
)
(3)
CHOEX
(
gmin−1
)
= V̇CO2
[(
Rexp − Rref
)
∕
(
Rexo − Rref
)]
∕k
(4)
Plasma CHO
(
gmin−1
)
= V̇CO2
[(
Rexp − Rref
)
∕
(
Rglu − Rref
)]
∕k
Endogenous CHO oxidation was calculated as the dif-
ferences between total CHO oxidation and exogenous CHO 
oxidation. The oxidation rate of muscle glycogen (g min−1), 
either directly or through the lactate shuttle (Brooks 1986), 
was calculated by subtracting plasma glucose oxidation from 
total carbohydrate oxidation (Eq. 5). Finally, the amount of 
glucose released from the liver was estimated as the differ-
ence between plasma glucose and exogenous carbohydrate 
oxidation (Eq. 6) (Peronnet et al. 1998):
Statistical analyses
The mean value observed for a given variable is presented 
with the associated standard deviation (mean ± SD) and 
where comparisons between conditions made, as the mean 
difference with associated confidence limits at the 95% level 
(mean, 95% CI range) with Cohen’s d effect size [e.g. mean 
difference, lower limit to upper limit (ES)] as recommended 
by Hopkins et al. (2009).
To provide meaningful terms to the effectiveness of CHO 
ingestion on exercise performance, a probabilistic magni-
tude-based inference analysis was conducted to analyse the 
effect of CHO ingestion on the mean power output during 
the 30-min TT. Using the coefficient of variation (2.4%) of 
laboratory cycling TT performance (Hopkins et al. 1999) 
and the smallest worthwhile change in athletic performance 
(0.5 × CV), the smallest meaningful effect in power output 
between conditions was computed to be 1.2%. The effect of 
CHO ingestion was expressed as a percentage change rela-
tive to placebo ingestion following back transformation of 
the mean of the natural logarithm of the power outputs. The 
chance that the true value of the effect was larger than the 
smallest meaningful effect on the 30 min TT was computed 
and qualitative terms assigned (Hopkins et al. 2009): < 1%, 
almost certainly not; < 5%, very unlikely; < 25%, unlikely 
or probably not; < 50%, possibly not; > 50%, possibly; > 
75%, likely or probable; > 95%, very likely; > 99% almost 
certain. For non-performance variables (heart rate, VO2, 
substrate oxidation, and plasma glucose and lactate, serum-
free fatty acid and insulin concentrations) where a smallest 
worthwhile change is difficult to calculate, statistical com-
parisons were also made using a one-way (dose) or two-way 
(dose x time) repeated measures ANOVA with Bonferroni 
post hoc adjustment (SPSS 20, IBM, New York, USA) as 
well as Cohen’s d effect sizes *(ES). ES threshold values 
were set as 0.2. 0.6, 1.2, 2.0, and 4.0 for small, moderate, 
(5)
Muscle oxidation
= total CHO oxidation − plasma glucose CHO oxidation,
(6)
Liver oxidation
= plasma glucose CHO oxidation − exogenous oxidation,
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large, very large, and extremely large effects, respectively 
(Hopkins et al. 2009).
Results
V̇O
2
 , V̇CO
2
 and heart rate
V̇O2 and V̇CO2 increased by a small but significant amount 
over time, i.e. between the 1st and 2nd hours (pooled data; 
ES = 0.19, P = 0.01 and ES = 0.01, P = 0.01, respectively, 
Table 1) and the 2nd and 3rd hours (pooled data; ES = 0.20, 
P = 0.01 and ES = 0.15, P = 0.014, respectively). There 
were small but significant differences in V̇CO2 between 
100 g h−1 and PLA during the 2nd and 3rd hours of the 
3-h ride (ES = 1.36 and 1.99, P = 0.02 and 0.01, see Table 1 
for comparisons); however, all other comparisons for V̇O2 
and V̇CO2 were not significantly different, producing small 
effects (ES < 0.55, P > 0.62). RER between CHO conditions 
was not different throughout the 3-h ride (ES = 0.02 to 0.22, 
P > 0.9), but was higher in all CHO conditions in the 2nd and 
3rd h relative to PLA (large ES > 1.41).
HR did not significantly increase between the 1st and 2nd 
hour or 2nd and 3rd hour of the constant load ride in any 
condition (main effect ES = 0.30, P = 0.19), Table 1. There 
were no differences between conditions during the 3-h ride 
(small effects, ES < 0.25, P = 1.00).
Total carbohydrate and fat oxidation
Total energy expenditure was not significantly differ-
ent between conditions for the 3 h of continuous cycling 
(PLA = 2803.9 ± 278.2 kCal, 80 g h−1 = 2874.0 ± 448.2 
kCal, 90  g  h−1 = 2878.6 ± 434.7 kCal, 100  g  h−1 = 
2978.3 ± 288.7.7 kCal, ES < 0.60, P > 0.18) or during the 3rd 
hour (PLA = 957.5 ± 110.8 kCal, 80 g h−1 = 978.8 ± 157.6 
kCal, 90  g  h−1 = 1000.1 ± 157.0 kCal, 100  g  h−1 = 
1016.6 ± 112.5 kCal, ES < 0.53, P > 0.16). In addition, no 
effects were seen between the 1st and 2nd hour or 2nd and 
3rd hour of exercise (Table 1; ES < 0.44, P > 0.25).
Absolute CHO oxidation during the 3-h ride was lower 
with ingestion of PLA relative to 80 g h−1 and 90 g h−1, 
a large but non-significant effect (ES = 1.20 and 1.36, 
P = 0.09 and 0.09), and significantly lower than 100 g h−1 
(very large effect, ES = 2.08, P = 0.002, see Table 1 for 
data). Absolute CHO oxidation followed the same pattern 
in the 3rd h of the 3-h ride; however, all effects were larger 
(ES = 1.40–2.35), with a significant difference between PLA 
and 100 g h−1 (P = 0.01). Differences between 80 g h−1 and 
90 g h−1 and PLA remained non-significant (P = 0.06 and 
0.064 respectively). In contrast, fat oxidation was highest 
Table 1  Respiratory gas 
exchange, heart rate and 
substrate utilisation over the 1st, 
2nd 3rd hours of the 3-h ride
Data are heart rate in b min−1, V̇O
2
 , V̇CO
2
 in L min−1, respiratory exchange ratio (RER), and CHO and fat 
oxidation in grams. The 1st hour is presented in the top line of each variable, and the 2nd hour in the mid-
dle line and the 3rd hour in the bottom line. All values are mean ± SD. a denotes PLA significantly lower 
than HGF
Condition
Hour Pla 80 g h−1 −190 g h 100 g h−1
HR (b min−1) 1st 136 ± 13 135 ± 12 136 ± 6 138 ± 12
2nd 140 ± 14 139 ± 13 140 ± 13 142 ± 13
3rd 145 ± 14 141 ± 13 144 ± 14 144 ± 13
VO2 (L min−1) 1st 2.91 ± 0.31 3.06 ± 0.46 2.87 ± 0.44 3.11 ± 0.36
2nd 3.03 ± 0.30 3.01 ± 0.49 3.00 ± 0.47 3.22 ± 0.34
3rd 3.12 ± 0.37 3.10 ± 0.49 3.13 ± 0.45 3.25 ± 0.42
VCO2 (L min−1) 1st 2.60 ± 0.27 2.77 ± 0.38 2.62 ± 0.36 2.84 ± 0.30
2nd 2.66 ± 0.27 2.78 ± 0.44 2.76 ± 0.42 3.00 ± 0.30
3rd 2.69 ± 0.30 2.87 ± 0.44 2.86 ± 0.41 3.02 ± 0.38
RER 1st 0.89 ± 0.03 0.91 ± 0.03 0.92 ± 0.03 0.91 ± 0.03
2nd 0.88 ± 0.03 0.92 ± 0.03 0.92 ± 0.03 0.93 ± 0.03
3rd 0.86 ± 0.03 0.92 ± 0.03 0.92 ± 0.03 0.93 ± 0.02
CHOox (g) 1st 149.6 ± 22.7 162.4 ± 28.7 166.6 ± 27.3 167.5 ± 18.3
2nd 144.0 ± 25.9 177.4 ± 33.0 182.5 ± 34.4 189.9 ± 19.6
3rd 137.5 ± 25.3 179.0 ± 32.6 185.4 ± 37.3 192.3 ± 19.8
Fatox (g) 1st 33.6 ± 10.0 30.1 ± 11.8 25.6 ± 9.2 28.8 ± 10.8
2nd 36.4 ± 9.2 24.0 ± 10.5 21.4 ± 8.8 23.4 ± 11.0
3rd 40.3 ± 10.3 24.1 ± 10.6 23.3 ± 8.6 23.8 ± 11.0
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with PLA ingestion producing a moderate to large effect for 
3-h ride, (ES = 1.05–1.51, P = 0.02 vs. 90 g h−1 and 0.04 vs. 
100 g h−1). However, in the 3rd hour, PLA fat oxidation was 
significantly higher (P = 0.008–0.02, large effects, ES = 1.55 
to 1.80). There were no differences between CHO conditions 
for total CHO or fat oxidation across the 3-h (ES < 0.42, 
P = 1.00) or the 3rd hour (ES < 0.49, P = 1.00).
In addition, the relative contribution of CHO to energy 
expenditure was higher with CHO ingestion (range 73. 7 
± 9.9–76.1 ± 8.4%) than PLA (61.7 ± 9.1%) for both the 
whole 3-h ride (large ES = 1.26–1.71, P = 0.021–0.05) and 
the 3rd h (large ES = 1.53–2.19, P = 0.005–0.04, Fig. 2). 
The lower relative CHO oxidation in PLA was associated 
with a concomitant large (and significant) increase in the 
relative contribution of fat to the energy yield compared 
with CHO ingestion (effect sizes and P values the same as 
reported for CHO). Additionally, there were no significant 
differences between CHO conditions for the relative con-
tribution of CHO and fat either during the whole 3-h ride 
(ES = 0.06–0.27, P = 1.00) or the 3rd hour (ES = 0.32–0.70, 
P = 0.24–1.00). However, the difference in the relative con-
tribution of CHO and fat in 90 g h−1 produced a moderate 
effect to 100 g h−1 (6.2% mean difference, P = 0.24).
δ 13CO2 in expired gas and δ 
13C in plasma glucose
The δ 13CO2 in expired gas was similar between all condi-
tions at rest before exercise (ES = 0.23–0.42, P = 0.37–1.00). 
In PLA, the δ 13CO2 in expired gas increased over time by 
1.4‰ (ES = 0.73) from the start to the end of exercise. 
These data were used as the background correction for the 
calculation of exogenous CHO and plasma glucose oxida-
tion for each CHO condition. The δ 13CO2 in expired gas 
significantly increased over time from the start of exercise 
following the ingestion of all three 13C enriched CHO solu-
tions (Fig. 1a). Each condition reached maximal values at 
180 min; however, no significant differences were observed 
between CHO conditions at any time point, despite a mod-
erately lower δ 13CO2 in 80 g h−1 relative to 90 g h−1 and 
100 g h−1 at 180 min.
The isotopic composition of plasma glucose (δ 13C) 
increased by 0.5‰ from 60 to 180 min of exercise with 
ingestion of PLA (ES = 0.32, P = 1.00, Fig.  1b). In all 
CHO conditions, there was a significant rise in plasma 
glucose δ 13C between 60 and 90 min (ES = 0.43–1.17, 
P = 0.002–0.05) which remained similar for all conditions 
between 90 and 180 min (ES = 0.07–0.35, P > 0.11). The 
isotopic composition of plasma glucose was highest for 
100 g h−1 during the last two hours of exercise, with a small 
effect (ES = 0.47–0.54) being relative to the other CHO con-
ditions until 180 min where a moderate effect was observed 
between 100 g h−1 and 80 g h−1 (ES = 0.74, P = 0.20).
Fig. 1  a 13CO2:12CO2 (δ13C) in expired air over the 3-h ride and b 13C:12C in plasma glucose during the second hour of the 3-h ride. See 
text for statistical and ES comparisons
Fig. 2  Percentage energy contributions from various substrates dur-
ing the hour 2 of the 3-h ride. See text for statistical and ES compari-
sons. Mgly – muscle glycogen oxidation, Lgly liver glycogen oxida-
tion
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Sources of oxidised glucose (exogenous 
and endogenous carbohydrate)
During the final hour of exercise, the rate of exogenous CHO 
oxidation was highest at the end of exercise (180 min) in all 
conditions with a small difference between 100 g h−1 and 
80 g h−1 and 90 g h−1 (ES = 0.39 and 0.55, P = 0.28 and 1.00 
respectively, Fig. 3a). There were no significant or moder-
ate or large effects observed at all other time points between 
conditions during the 3-h ride. The absolute oxidation of 
exogenous CHO was moderately higher (8.1 and 9.6 g, 
ES = 0.64 and 0.96) in 100 g h−1 than 80 g h−1 and 90 g h−1 
respectively, but was not significantly different between 
CHO conditions in the 2nd hour (P = 0.07–1.00). A similar 
magnitude of difference between conditions was seen in the 
final hour, but no significant differences were detected in the 
absolute oxidation of exogenous CHO, despite a moderate 
effect (ES = 0.64 and 0.70) between 100 g h−1 and 80 g h−1 
and 90 g h−1 respectively (P = 0.11–1.00). The relative 
contribution of exogenous CHO to total energy expendi-
ture was not significantly different in the 2nd hour (range 
25.6 ± 4.6–27.5 ± 4.2, ES < 0.44, P > 0.33) or the 3rd hour 
(ES < 0.56, P > 0.28, Fig. 2). The relative contribution of 
exogenous CHO was significantly greater (large effect size) 
in the final hour than the 2nd hour (ES > 1.78, P < 0.01).
Compared with PLA, CHO ingestion caused a moder-
ate reduction in the absolute amount of endogenous CHO 
oxidised in the 3rd hour of exercise with 80 g h−1 (30.4, 
8.3 to 52.6 g, P = 0.13, ES = 1.12) and 100 g h−1 (23.1, 5.3 
to 40.9, P = 0.35, ES = 0.99) and a large reduction with 
90 g h−1 (36.6, 14.4 to 58.8, P = 0.13, ES = 1.22, Table 2). 
During the 2nd hour, all differences to PLA were moderate 
(ES = 0.68–0.97) but non-significant, (P > 0.37). Differences 
in absolute endogenous CHO oxidation between CHO con-
ditions were not significantly modified during the 3rd hour 
of exercise. With 90 g h−1, a small reduction was seen rela-
tive to 80 g h−1 (− 6.2, − 22.0 to 9.7 g, P = 1.00. ES = 0.21) 
and 100 g h−1 (− 13.5, − 29.4 to 2.3, P = 0.75, ES = 0.51).
With 100 g h−1, plasma glucose oxidation rates increased 
more quickly, producing moderate, but non-significant dif-
ferences to 80 and 90 g h−1 at 90 and 120 min (ES = 0.72 
and 0.68, P = 0.91 and 0.93). At 150 and 180 min, the rate 
of plasma glucose oxidation remained slightly higher with 
100 g h−1, but differences to 80 and 90 g h−1 became small 
(150 min, ES = 0.42 and 0.46, P = 1.00; 180 min, ES = 0.43 
and 0.28, P = 1.00). Absolute plasma glucose oxidation in 
Fig. 3  Sources of oxidised glucose and muscle glycogen during hours 2 and 3 of the 3-h ride. See text for statistical and ES comparisons
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the 3rd hour was not significantly different between condi-
tions, with all differences producing small effects (ES = 0.00 
to 0.42, P = 0.34–1.00, Table 2).
Similarly, rates of liver-derived glucose oxidation 
(Fig. 3d) were not significantly different between CHO 
conditions. When the CHO dose was increased from 80 to 
90 g h−1, effects did not exceed > 0.26 at any time point in 
the last 2 h of exercise (P = 1.00). With 100 g h−1, a small 
reduction was observed (ES = 0.22–0.53, P = 0.34–0.80). 
During the 3rd hour of exercise, the total amount of glucose 
released from the liver was the same between 80 and 90 g h−1 
(9.0 vs. 9.1 g) but slightly higher with 100 g h−1 (ES = 0.40 
and 0.42 respectively, P = 0.70 and 0.31). Expressed as the 
relative contribution to total energy expenditure during the 
3rd hour, these effects remained small with 100 g h−1 pro-
viding a greater contribution than 80 g h−1 (1.3, − 0.4 to 
3.0%, ES = 0.51, P = 0.30) and 90 g h−1 (1.2, − 0.1 to 2.4, 
ES = 0.47, P = 0.56, Fig. 2).
Rates of muscle glycogen oxidation were not different 
between conditions at 60 min (ES < 0.28, P = 1.00, Fig. 3c) 
but became slightly attenuated with 90 g h−1 relative to 
100 g h−1 from 75 min onwards. Throughout the 2nd and 
3rd hours of the 3-h ride, differences in the rate of muscle 
glycogen oxidation between 80 and 90 g h−1 were not sig-
nificantly different (ES < 0.31, P > 0.84) except at 180 min, 
where the difference was greatest, producing a moder-
ately lower rate with 90 g h−1 (0.32, 0.00 to 0.60 g.min−1, 
ES = 0.66, P = 0.12). Throughout the 2nd and 3rd h, the rate 
of muscle glycogen oxidation remained moderately lower 
with 90 g h−1 than 100 g h−1 with the greatest difference 
also seen at 180 min, though effects were not significantly 
different (0.27, 0.01 to 0.53, ES = 0.65, P = 0.20). With 
Table 2  Comparisons of CHO 
oxidation source during the 
third hour
Values given are comparisons of CHO oxidation from various sources over the third hour of the 3 h ride 
between 80 g h−1, 90 g h−1 and 100 g h−1 glucose: fructose ingestion. [1st line: mean ± s.d., absolute dif-
ference between conditions with associated 95% confidence intervals; 2nd line: Cohen’s d effect size and P 
value (ANOVA with Bonferroni post hoc comparison)]
CHO Ox (g) Difference in CHO oxidation (g)
Low Med
Exogenous CHO
 80 g h−1 81.6 ± 17.0
 90 g h−1 82.9 ± 11.2 1.3, − 9.4 to 12.1
ES = 0.09, P = 1.00
 100 g h−1 91.1 ± 12.3 9.6, 1.4 to 17.7
ES = 0.64, P = 0.10
8.2, 2.1 to 18.6
ES = 0.70, P = 0.39
Endogenous CHO
 80 g h−1 100.7 ± 27.1
 90 g h−1 94.5 ± 32.6 6.2, − 22.8 to 10.5
ES = 0.21, P = 1.00
 100 g h−1 108.0 ± 18.8 7.3, − 9.0 to 23.8
ES = 0.32, P = 1.00
13.5, − 3.1 to 30.2
ES = 0.51, P = 0.37
Plasma glucose
 80 g h−1 90.6 ± 15.0
 90 g h−1 92.0 ± 8.5 1.4, − 6.4 to 9.1
ES = 0.11, P = 1.00
 100 g h−1 97.6 ± 14.6 7.0, − 1.3 to 15.3
ES = 0.47, P = 0.34
5.6, − 3.3 to 14.5
ES = 0.47, P = 0.67
Liver glycogen
 80 g h−1 9.0 ± 7.6
 90 g h−1 9.1 ± 7.1 0.1, − 4.3 to 4.3
ES = 0.00, P = 1.00
 100 g h−1 6.4 ± 5.2 − 2.6 − 6.8 to 1.6
ES = 0.40, P = 0.70
− 2.6, − 5.6 to 0.4
ES = 0.42, P = 0.31
Muscle glycogen
80 g h−1 91.6 ± 24.6
90 g h−1 85.4 ± 29.3 6.2, − 23.5 to 11.1
ES = 0.23, P = 1.00
100 g h−1 101.6 ± 16.6 10.0, − 5.1 to 25.0
ES = 0.47, P = 0.61
16.1, 0.9 to 31.4
ES = 0.68, P = 0.16
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100 g h−1, the absolute amount of muscle glycogen oxidised 
in the final hour of exercise was higher than 80 g h−1 (10.0, 
− 5.1 to 25.0 g, ES = 0.47, P = 0.61) and 90 g h−1 (16.1, 0.9 
to 31.4 g, ES = 0.68, P = 0.16). The difference between 80 
and 90 g h−1 was small (− 6.2, − 23.5 to 11.1 g, ES = 0.23, 
P = 1.00). In terms of the relative contribution to total energy 
expenditure, the effect of CHO on muscle glycogen oxida-
tion when the dose was increased from 90 to 100 g h−1 
was also moderate (5.6, 0.9 to 10.3%, ES = 0.72, P = 0.12, 
Fig. 2). The difference between 80 and 90 g h−1, though 
still lower with 90 g h−1 was small (− 3.5, − 10.8 to 3.7%, 
ES = 0.36, P = 1.00).
Circulatory metabolites and insulin
Plasma glucose concentration increased at the onset of exer-
cise with CHO ingestion, peaking at 6.8 ± 1.2 mmol L−1 
with 100 g h−1, with only minimal differences between 
CHO conditions (ES < 0.17, P = 1.00, Fig. 4a). From 45 min 
onwards, there remained no differences between CHO 
conditions for plasma glucose during the entire 3-h ride. 
Plasma glucose was consistently lower in PLA than with 
CHO ingestion, with differences to all CHO conditions in 
the final hour significant and large (ES > 1.26, P < 0.045). 
Plasma lactate did not differ between conditions with mean 
concentrations during the 3-h ride of 1.5 ± 0.9 in PLA to 1.9 
± 0.8 with 80 g h−1 (ES < 0.4, P = 1.00, Fig. 4b). Serum-free 
fatty acid concentrations were increasing and significantly 
Fig. 4  Circulatory metabolites, plasma glucose and lactate, serum-free fatty acids and insulin concentrations during the 3-h ride. See text for 
statistical and ES comparisons
Fig. 5  Power output during the 30-min time trial with individual per-
formance data. See text for statistical and ES comparisons
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higher in PLA than with CHO ingestion from 60  min 
onwards, ES > 1.75, P < 0.05, Fig. 4c but were unchanged 
between CHO doses at all time points (ES < 0.8, P = 1.00). 
Serum insulin concentrations were significantly lower in 
PLA than with CHO ingestion in the 2nd and 3rd hours 
(ES > 1.8, P < 0.012, Fig. 4d) and declined during this period 
in PLA (2.3, 1.4 to 3.1 µU.L−1, ES = 1.48, P = 0.024). There 
were, however, no significant differences between CHO 
conditions in the 2nd and 3rd hours (ES < 0.58, P > 0.72) 
except at 150 and 180 min, where insulin concentrations 
were moderately, but not significantly, lower with 80 g h−1 
than 90 and 100 g h−1 (ES = 0.71 and 0.81, P = 0.74 and 
0.70, respectively).
Time trial performance
Power output in the 30 min time trial was highest with 
90 g h−1 (228 ± 37 W, Fig. 5). This was a 6.8% higher 
power output than 100 g h−1 (212 ± 48 W) and calculated 
to be a 93.0% likely/probable meaningful effect (14.8, 
− 0.4 to 30.1 W, ES = 0.40, P = 0.52 [Bonferroni]). Com-
pared with 80 g h−1 (219 ± 32 W), this resulted in a 4.0% 
higher power output (8.8, − 0.6 to 18.3 W, ES = 0.26, 
P = 0.68), an 86.5% likely/probable meaningful effect. 
Against the placebo condition (186 ± 37 W), all 3 CHO 
doses produced a higher average power output (range 26.8 
to 41.7 W, ES = 0.62 to 1.12, P = 0.012 to 0.001).
Discussion
The data from the present study partially confirm our 
hypothesis that the ingestion rate of glucose–fructose 
solutions above previously reported intestinal saturation 
rates during 3 h of exercise negatively influenced sub-
sequent time trial performance. This is likely explained 
by an increased reliance on muscle glycogen, rather than 
any real changes in exogenous CHO oxidation or glucose 
released from the liver. The effects were not statistically 
significant when multiple comparisons were accounted for 
but the observed effects were moderate and/or meaningful 
in the context of endurance exercise performance.
There were no observed changes in liver glycogen oxi-
dation but a moderate (although non-significant) increase 
in muscle glycogen oxidation was seen when the dose of 
ingested CHO exceeded 90 g h−1, the primary findings of 
this investigation. Exogenous CHO oxidation increased 
when the CHO dose was marginally elevated above pre-
viously reported intestinal saturation rates for glucose 
and fructose, peaking at 1.60 g.min−1. In line with previ-
ous data, exogenous CHO ingestion spared fat oxidation 
and this was seen in all CHO doses (Smith et al 2019; 
Wallis et al. 2006). Finally, we observed that time trial 
performance following the 3-h prolonged ride was also 
superior with 90 g h−1, a novel finding with regard to exer-
cise performance of this duration with exogenous CHO 
provision. Taken together, this suggests that the dose of 
ingested CHO should not exceed reported intestinal satura-
tion rates as previously shown.
We previously reported that endurance exercise per-
formance is diminished if rates of ingested CHO signifi-
cantly exceed ≈ 60 g h−1 for glucose and 90 g h−1 for glu-
cose–fructose mixtures (King et al. 2018). In the current 
study, exercise performance, measured by a 30-min time 
trial following a 3-h steady state ride at moderate intensity, 
was 3.7% and 7.5% higher with ingestion of 90 g h−1 than 
with 80 and 100 g h−1 respectively, suggesting a similar, 
albeit slightly smaller effect. Similar improvements have 
previously been reported, but largely only in comparison 
to placebo ingestion or isocaloric CHO strategies of dif-
fering composition (Angus et al. 2000; Currell and Jeuke-
ndrup 2008; Hulston et al. 2009; Madsen et al. 1996; Row-
lands et al. 2008; Smith et al. 2010; Tripplett et al. 2010).
However, there are less data to draw upon when the 
total exercise duration is equal to or greater than 3 h. Con-
flicting data exist on the effect of CHO ingestion vs. pla-
cebo on 100 km TT performance, which in trained cyclists 
is of similar duration to the current study (Angus et al. 
2000; Madsen et al. 1996). In these studies, both a benefi-
cial effect (Angus et al. 2000) and no effect (Madsen et al. 
1996) were observed when using similar doses of glu-
cose (60 g h−1). In terms of CHO composition, Tripplett 
et al. (2010) reported improved 100 km TT time with glu-
cose–fructose ingestion (108 g h−1) compared with an iso-
caloric dose of glucose only, supporting the need for mul-
tiple transportable CHO in prolonged (< 2.5 h) exercise. 
In the most comprehensive assessment of CHO dose and 
exercise performance to date, Smith et al. (2013) found the 
dose:performance relationship to be curvilinear, model-
ling an upper ingestion rate of 88 g h−1, which data from 
the current study support, where ingesting 100 g h−1 was 
detrimental. However, the possible physiological mecha-
nisms supporting a CHO dose effect were not explored 
in these studies to which the present study provides new 
evidence. The improved performance in the current study 
also provides novel data to the sensitivity of metabolic 
responses to CHO doses that fall above and below the 
suggested ingestion rate of 90 g h−1 for prolonged exercise 
(Jeukendrup 2014).
It should be noted, however, that the magnitude of per-
formance loss seen in the CHO doses above and below the 
best performance with 90 g h−1 in the current study did 
not reach statistical significance. However, with the often 
small margins of victory in endurance events, the observed 
improvement in power output in the 30-min TT (9–16W) 
was calculated to be likely/probable to be a meaningful 
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effect. However, to detect meaningful changes in athletic 
performance, a move to enhance statistical analysis by 
including measures alongside traditional null hypothesis 
testing has been suggested (Bernards et al. 2017; Deighton 
et al. 2017). This study provides evidence that even small 
alterations in the ingested dose of CHO during exercise may 
impact subsequent time trial performance. This interpreta-
tion should be taken cautiously despite providing small to 
moderate effects, with 8 of 11 of the participants recording 
a superior power output with 90 g h−1. Translation to the 
greater population should be considered with some caution, 
but individual responses are important in terms of planning 
individualised nutrition strategies for endurance perfor-
mance (Jeukendrup 2017).
Rates of exogenous CHO oxidation reached 1.60 g min−1 
with 100 g h−1, although this was not significantly higher 
than the lower doses of 80 and 90 g h−1. However, all doses 
produced exogenous oxidation rates higher than 1 g min−1 
due to the presence of fructose and non-competitive intesti-
nal transport. Similarly, over the last hour of exercise, when 
CHO provision may be most impactful, the total amount of 
exogenous CHO utilised, namely by contracting muscle, was 
moderately higher with 100 g h−1 (though not significantly 
different) than both 80 and 90 g h−1. Such high exogenous 
CHO oxidation rates are comparable with the existing litera-
ture, but only with very high (135 g h−1 glucose–fructose) 
CHO ingestion rates (Jentjens et al. 2004a, b; Jentjens and 
Jeukendrup 2005). However, these studies did not report 
contributions of liver and muscle glycogen oxidation during 
(2 h) continuous cycling. Furthermore, it is also not possible 
to determine if the extremely high rates of exogenous CHO 
oxidation were beneficial to performance in these investi-
gations, as no measure of performance was included. Data 
from our laboratory (King et al. 2018) support earlier work 
by Smith et al. (2013) suggesting that the very high doses 
used in those studies would actually be detrimental to endog-
enous fuel selection and performance. In the current study 
a small, but ‘likely/probable’ decrease in performance was 
seen despite a consistently moderate (~ 6–10%) higher rate 
of exogenous CHO oxidation with 100 g h−1.
Interestingly, the rate of exogenous CHO oxidation con-
tinued to rise throughout the 3-h ride. Jeukendrup et al. 
(2006) observed a similar rise until the same duration into 
exercise, when exogenous CHO oxidation plateaued during 
a 5-h exercise period with similar CHO ingestion (90 g h−1 
glucose–fructose). Why exactly this rise occurs remains to 
be elucidated, but it is possible that in the early stages of 
exercise, or during shorter duration exercise, a portion of 
the ingested CHO is taken up by non-exercising peripheral 
tissues and not subsequently oxidised. It is known that gly-
cogen synthase activity is directly upregulated by muscle 
contraction (Nielsen and Richter 2003) and in this phase 
of exercise this mechanism may serve to spare muscle 
glycogen before the prolonged demands of an exercise bout 
require activation of glycogen phosphorylase and reduction 
in glycogen synthase activity to enable the maintenance of 
exercise intensity. A limitation of the 13C tracer technique 
is the inability to differentiate any partitioning of ingested 
substrates, for which a dual tracer technique is required (Jeu-
kendrup et al. 1999a, b). However, this effect may indicate 
that to some extent ingesting CHO during the early stages 
of exercise may provide a cumulative effect later in exercise 
when glycogen availability and oxidation are significantly 
lower, as observed in the current study.
The effect of exogenous CHO feeding on endogenous fuel 
utilisation has previously highlighted reductions in hepatic 
glucose production (Jeukendrup et al. 1999a, b) or liver gly-
cogen oxidation (Wallis et al. 2006) as well as sparing of 
muscle glycogen (Tsintzas et al. 1996, 2001) as possible 
mechanisms to explain the ergogenic effect of CHO sup-
plementation during endurance exercise. Furthermore, the 
role of multiple transportable CHO ingestion is now estab-
lished to be beneficial over single (glucose or maltodextrin) 
source CHO for delivering higher rates of exogenous CHO 
oxidation and the potential to spare endogenous glycogen. 
However, the current study demonstrates for the first time 
that small alterations in the dose of ingested glucose–fruc-
tose modify endogenous fuel selection in line with small but 
meaningful (likely/probable) improvements in power out-
put in a self-paced TT following 3 h of cycling. Based on 
previous research in similarly trained cyclists, we observed 
a significant and negative upregulation of total, liver and 
muscle CHO oxidation during 2 h of prolonged cycling 
when exogenous CHO delivery at 112.5 g h−1 exceeded 
intestinal absorption rates (King et al. 2018). Such an ‘over-
dose’ effect appears to also diminish power output at the 
end stages of exercise, where in racing scenarios, the ability 
to perform at a higher exercise intensity is often required. 
Data from the current study suggest that a CHO ‘over-dose’ 
of lesser extent also provides a suboptimal modification of 
muscle glycogen utilisation but this effect also appears to 
be sensitive to the level of CHO consumed above intestinal 
saturation rates. The precise mechanism(s) explaining the 
loss of power output with CHO ingestion rates beyond the 
intestinal saturation levels has not yet been fully determined. 
However, exceeding doses of 90 g h−1 of glucose–fructose 
should be avoided in endurance exercise to mitigate the pos-
sible performance losses seen with increased reliance on 
muscle glycogen.
With the 90 g h−1 dose, a moderate reduction in the rate 
of muscle glycogen oxidation at 180 min was seen, sup-
porting our previous findings (King et al. 2018). However, 
this was not statistically significant with multiple compari-
sons accounting for the ingestion of CHO above and below 
previously reported intestinal saturation limits. A limita-
tion present in our study design is the lack of regulatory 
1168 European Journal of Applied Physiology (2019) 119:1157–1169
1 3
metabolic data that may provide further mechanistic detail 
at the muscle fibre in response to CHO feeding. With the 
observed increase in muscle glycogen oxidation, it stands 
that glycogen phosphorylase activity is increased, perhaps 
through CHO driven regulation of glycolysis. Indeed, a mod-
erate reduction in the provision of fat to energy expenditure 
was also seen when the ingested CHO dose increased from 
90 to 100 g h−1. This could perhaps be due to the slightly 
higher insulin concentrations during the 3rd hour (small ES 
at 120 and 150 min) suppressing adipose tissue FFA release, 
or through a non-insulin-dependent mechanism. Where fat 
oxidation is suppressed through insulin action and beta-oxi-
dation-derived acetyl CoA is reduced, upregulation of PDH 
(and PKA) activity is increased to maintain energy require-
ments to the working muscle. Further, the action of adrena-
line may stimulate glycogenolysis via β-adrenergic receptors 
and glycogen phosphorylase phosphorylation and glycogen 
synthase dephosphorylation by cAMP (Cohen 2002; Jensen 
and Richter 2012). However, future research should focus 
on the molecular and cellular modifications that exogenous 
CHO provision initiates.
Conclusion
This study demonstrates that the ingestion of up to 90 g h−1 
of carbohydrate (2:1 of glucose and fructose) is optimal 
for time trial performance following 3 h of sub-maximal 
exercise compared to higher doses and a non-CHO solu-
tion. However, there were only small alterations in substrate 
metabolism, with the exception of muscle glycogen. The 
moderately increased reliance on muscle glycogen observed 
with glucose–fructose ingestion above the previously 
reported intestinal saturation limits is a plausible explanation 
for the decreased performance at 100 g h−1. Supporting pre-
vious evidence that the CHO dose:performance relationship 
is not linear and that ‘over-dosing’ with exogenous CHO 
may be detrimental, the current study provides new evidence 
to answer the question of not achieving recommended CHO 
intakes of 90 g h−1 by small amounts. Here, our data suggest 
that the “over-dose” effect, whereby effective and beneficial 
muscle glycogen oxidation and exercise performance are 
diminished, is potentially sensitive to exceeding this target 
by as little as 10 g h−1. Therefore, it should be recommended 
that the rate of ingestion should reach, but not exceed intes-
tinal saturation for glucose and fructose. Future research is 
warranted to confirm the precise mechanism at the muscle 
fibre level behind this effect in prolonged exercise.
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